fb-pixel Skip to main content
Mass. coronavirus at a glance
High Med. Low
.
Select a county:
COVID 19 community level from CDC:
.
Case Rate per 100,000 population:
.
New COVID-19 admissions per 100,000:
.
Total cases:
Total deaths:

Recent coronavirus news & features

More coronavirus stories


BPS families group pushes for masking requirements as Chelsea schools and UMass Boston reinstate mandates

The push for stricter COVID safety protocols comes after the CDC on Friday designated Suffolk County’s community risk level for COVID-19 as “high.”

UMass Boston reinstates indoor mask requirements amid rising COVID rates

The university decided to reinstate the policy because of rising COVID positivity and hospitalization rates, as well as the rise of a new subvariant called XBB, according to a Friday announcement.

Coronavirus levels rise sharply in Eastern Mass. waste water

Virus levels detected in both the northern and southern sections of the MWRA system rose to their highest points in months, with levels nearly doubling since the end of November.

Charts: Who has been vaccinated in Massachusetts, and how many doses has the state received?

The charts break down vaccination recipients by age, vaccination date, location, and race/ethnicity, while also outlining vaccination brand and administration site type.

What we know about XBB, the new dominant COVID variant in New England

A new coronavirus variant dubbed XBB has swiftly become the dominant form of COVID-19 spreading in the Northeast, jumping from about 35 percent of cases during the week ending Dec. 17 to just over half last week, according to CDC data.

The Globe’s 10 most read stories of 2022

With the year drawing to a close, we took a look back at the stories that resonated with readers the most.

US announces new COVID-19 testing requirement for travelers from China

The US will require airline passengers coming from China to show negative COVID-19 tests as global concerns ratchet higher over the virus’s spread since the country lifted its restrictions.

Drug companies set sights on new COVID medicines to boost depleted arsenal

The newest coronavirus variants have rendered two important antibody therapies ineffective.